Consistent Benefit of Sacubitril/Valsartan: More from PARADIGM-HF
Scott Solomon, MD, Director of Noninvasive Cardiology, Brigham and Women's Hospital and a Professor of Medicine, Harvard Medical School talks to CSWN about the PARADIGM-HF study results presented at ACC.16 in Chicago.
▶︎
New Agents for Heart Failure: Sacubitril/Valsartan
▶︎
Safest BLOOD PRESSURE Medications in 2026
▶︎
Sacubitril/Valsartan : Should We Reshuffle the Deck in the Treatment of HF?
▶︎
Posture, Bone Density & Muscle: A Stanford Doctor Destroys Aging Myths Most People Believe
▶︎
The World's Most Important Machine
▶︎
Entresto (Sacubitril / Valsartan) Explained, the Good and the Bad: Side Effects and How I Use it.
▶︎
Success of ARNI Continue in 2019: Effective in Acute and Diastolic Heart Failure? - Dr. Jim Januzzi
▶︎
Top 3 Fruits for DIABETICS To Eat (Lowers Blood Sugar)| Dr. Alan Mandell
▶︎
Billionaire's WARNING: I'm SELLING. The Crash Is Already Here!
▶︎
Sacubitril/Valsartan (Entresto®) - The Core Four
▶︎
SGLT2 Inhibitors and Heart Failure
▶︎
Kidney Failure Treatment Options
▶︎
HFSA 2022: PROVE-HF: Effect of Sacubitril/Valsartan in HFrEF Pts With MR | Dr James L Januzzi
▶︎
New Hope for Heart Failure patients- A gamechanger arrives
▶︎
ACE inhibitors and ARBs for Heart Failure
▶︎
Management of Aortic Aneurysms
▶︎
SGLT2 Inhibitors in Chronic Kidney Disease
▶︎
Entresto | Uses Side Effects & Precautions
▶︎
ARNI (Sacubitril-Valsartan or Entresto) and SGLT2 Inhibitors for Heart Failure
▶︎